Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| UBE2I depletion regulated tumor-associated macrophage polarization into M1 type through reprogramming glycolysis and increases immunotherapy efficacy of anti-PD-L1 in ovarian cancer. | Mol Immunol | 2025 | 39919348 | PubTator, text mining | PubMed |
| Novel PDGFRB Gene Fusions in Two Cases of Infantile Myofibromatosis. | Genes Chromosomes Cancer | 2025 | 39873217 | PubTator, text mining | PubMed |
| Cell Type Specific Suppression of Hyper-Recombination by Human RAD18 Is Linked to Proliferating Cell Nuclear Antigen K164 Ubiquitination. | Biomolecules | 2025 | 39858544 | PubTator, text mining | PubMed |
| Small molecule targeting Na V 1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model. | Pain | 2025 | 39106443 | PubTator, text mining | PubMed |
| Recent Advances on the Regulations of Organic Anion Transporters. | Pharmaceutics | 2024 | 39598479 | PubTator, text mining | PubMed |
| DNA methylation biomarkers and myopia: a multi-omics study integrating GWAS, mQTL and eQTL data. | Clin Epigenetics | 2024 | 39538342 | PubTator, text mining | PubMed |
| Computational insights into irinotecan's interaction with UBE2I in ovarian and endometrial cancers. | Comput Biol Chem | 2024 | 39476484 | PubTator, text mining | PubMed |
| Balancing acts: The posttranslational modification tightrope of flavivirus replication. | PLoS Pathog | 2024 | 39466723 | PubTator, text mining | PubMed |
| Effects of Mixtures of Emerging Pollutants and Drugs on Modulation of Biomarkers Related to Toxicity, Oxidative Stress, and Cancer. | Metabolites | 2024 | 39452940 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Identification and validation of reference genes for RT-qPCR analysis in Iris domestica under Cd stress. | Heliyon | 2024 | 39281568 | PubTator, text mining | PubMed |
| An Atypical Mechanism of SUMOylation of Neurofibromin SecPH Domain Provides New Insights into SUMOylation Site Selection. | J Mol Biol | 2024 | 39216515 | PubTator, text mining | PubMed |
| Dysregulated gene expression of SUMO machinery components induces the resistance to anti-PD-1 immunotherapy in lung cancer by upregulating the death of peripheral blood lymphocytes. | Front Immunol | 2024 | 39211047 | PubTator, text mining | PubMed |
| The role of ubiquitin-conjugating enzyme in the process of spermatogenesis. | Reprod Biol Endocrinol | 2024 | 39198846 | PubTator, text mining | PubMed |
| Heterochromatin formation and remodeling by IRTKS condensates counteract cellular senescence. | EMBO J | 2024 | 39192031 | PubTator, text mining | PubMed |
| Unraveling the molecular pathogenesis of Type 2 Diabetes and its impact on female infertility: A bioinformatics and systems biology approach. | Comput Biol Med | 2024 | 39116715 | PubTator, text mining | PubMed |
| RREB1-mediated SUMOylation enhancement promotes chemoresistance partially by transcriptionally upregulating UBC9 in colorectal cancer. | Front Pharmacol | 2024 | 39108750 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Protein SUMOylation promotes cAMP-independent EPAC1 activation. | Cell Mol Life Sci | 2024 | 38963422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=5